Centrexion Therapeutics is a late clinical-stage biopharmaceutical company focused on becoming a leader in identifying, developing and commercializing novel, non-opioid and non-addictive therapies to address the large unmet medical need for the treatment of chronic pain.

Education

Pharmaceutical

Biotechnology

Centrexion Therapeutics

Jeffrey B. Kindler

Ryan Shultz

Amy Conley

James Connolly

Pamela Gifford - Isaacson

Lynne Sole

Colleen Newman

James N. Campbell

Mike Ward

Jonathan Guerriero

Randall Stevens

Leadership Team

Clinical Operations and Development

Teams at Centrexion Therapeutics

Leadership Team

Clinical Operations and Development